Clinical Trials
4
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
An Extension Study MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue
- Conditions
- Neoplasms of the Prostate
- First Posted Date
- 2020-01-27
- Last Posted Date
- 2023-05-18
- Lead Sponsor
- Nanospectra Biosciences, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT04240639
- Locations
- 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
🇺🇸Mayo Clinic Urology, Rochester, Minnesota, United States
🇺🇸Washington University in St. Louis, Saint Louis, Missouri, United States
MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue
- Conditions
- Neoplasms of the Prostate
- First Posted Date
- 2016-02-11
- Last Posted Date
- 2021-03-03
- Lead Sponsor
- Nanospectra Biosciences, Inc.
- Target Recruit Count
- 45
- Registration Number
- NCT02680535
- Locations
- 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸University of Michigan, Ann Arbor, Michigan, United States
🇺🇸Icahn School of Medicine at Mount Sinai, New York, New York, United States
Efficacy Study of AuroLase Therapy in Subjects With Primary and/or Metastatic Lung Tumors
- Conditions
- Primary or Metastatic Lung Tumors
- First Posted Date
- 2012-09-06
- Last Posted Date
- 2016-11-03
- Lead Sponsor
- Nanospectra Biosciences, Inc.
- Target Recruit Count
- 1
- Registration Number
- NCT01679470
- Locations
- 🇺🇸
Cancer Treatment Centers of America Eastern Regional Medical Center, Philadelphia, Pennsylvania, United States
Pilot Study of AuroLase(tm) Therapy in Refractory and/or Recurrent Tumors of the Head and Neck
- Conditions
- Head and Neck Cancer
- First Posted Date
- 2009-02-20
- Last Posted Date
- 2017-02-09
- Lead Sponsor
- Nanospectra Biosciences, Inc.
- Target Recruit Count
- 11
- Registration Number
- NCT00848042
- Locations
- 🇺🇸
Cancer Treatment Centers of American Western Regional Medical Center, Goodyear, Arizona, United States
🇺🇸Baylor College of Medicine, Houston, Texas, United States